Marc J Bayer, MD in Avon, CT - Emergency Medicine

Marc J Bayer, MD is a Emergency Medicine - Medical Toxicology physician based in Avon, Connecticut. Marc J Bayer is licensed to practice in Connecticut (license number 032539) and his current practice location is 10 Wyndemere, Avon, Connecticut. He can be reached at his office (for appointments etc.) via phone at (860) 676-1444.

NPI number for Marc J Bayer is 1598761918 and his current mailing address is 10 Wyndemere, Avon, Connecticut. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1598761918.

Contact Information

	Marc J Bayer, MD
	10 Wyndemere, Avon, CT 06001-3959
	(860) 676-1444
	Not Available

Physician's Profile

Full Name	Marc J Bayer
Gender	Male
Speciality	Emergency Medicine - Medical Toxicology
Location	10 Wyndemere, Avon, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1598761918
Provider Enumeration Date: 06/21/2005
Last Update Date: 03/20/2018

Medical Identifiers

Medical identifiers for Marc J Bayer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1598761918	NPI	-	NPPES
1598761918	Medicaid	CT

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207PT0002X	Emergency Medicine - Medical Toxicology	032539 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Marc J Bayer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Marc J Bayer, MD 10 Wyndemere, Avon, CT 06001-3959 Ph: (860) 676-1444	Marc J Bayer, MD 10 Wyndemere, Avon, CT 06001-3959 Ph: (860) 676-1444

News Archive

No intervention is necessary for most children with fluid in their ears

A Children's Hospital of Pittsburgh study finds that prompt insertion of tympanostomy tubes (small ear tubes) does not improve developmental outcomes of children at 6 years of age as once thought.

Modeling study sheds light on SARS-CoV-2 genome packaging

Researchers at the University of North Carolina at Chapel Hill have conducted a study exploring how the spatial patterning of certain genomic RNA regions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes compaction, packaging, and cyclization of the viral genome.

Administration moving the 'right way' by emphasizing global health coordination at country levels

The recent announcement "that the Administration's signature Global Health Initiative (GHI) was being replaced by a new Office of Global Health Diplomacy at State was greeted with withering criticism from many in the global health community," PSI CEO Karl Hofmann writes in this post in the organization's "Healthy Lives" blog.

COVID-19 linked to newborn complications

A recent study discusses whether pregnant women with the COVID-19 are at a higher risk for poor outcomes for themselves and their babies.

Gene therapy holds promise for Parkinson's treatment

A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.

Marc J Bayer, MD - Emergency Medicine in Avon, CT